直肠癌术前放疗联合局部切除:一项随机研究的长期结果
这项III期随机研究比较了短程放疗与放化疗后局部切除治疗早期直肠癌的长期疗效。结果显示,短程放疗组的10年局部复发率更高(35% vs 5%,p=0.036),总生存率更低(47% vs 86%,p=0.009)。未行补行全直肠系膜切除术(CTME)的ypT1R1/ypT2-3患者10年局部复发率高达79%。
要点
- 短程放疗后局部复发高于放化疗(10年:35% vs 5%,p=0.036)。
- 短程放疗后总生存低于放化疗(10年:47% vs 86%,p=0.009)。
- ypT1R1/ypT2-3未行CTME者10年局部复发达79%。
核心结论
- 在局部切除背景下,短程放疗后的局部复发和生存均劣于放化疗。
- 由于存在偏倚风险,需要确证性研究。
- 未行补行全直肠系膜切除术与不可接受的高局部复发率相关。
研究设计与样本
- III期随机研究,纳入cT1-2N0M0或临界cT2/T3N0M0且<4 cm的直肠腺癌患者。
- 随机分为短程放疗组(5×5 Gy plus 1×4 Gy boost)或放化疗组(50.4 Gy/28次 plus 3×1.8 Gy boost,联合5-氟尿嘧啶和亚叶酸钙)。
- 局部切除在6-8周后进行;ypT0-1R0者观察,ypT1R1/ypT2-3者推荐补行CTME。
- 61例随机,排除10例,51例分析(短程组29例,放化疗组22例)。
主要发现
- ypT0-1R0在短程组占66%,放化疗组占86%,p=0.11。
- 仅46%的ypT1R1/ypT2-3患者接受了CTME。
- 中位随访8.7年,10年局部复发率短程组vs放化疗组为35% vs 5%,p=0.036。
- 10年总生存率短程组vs放化疗组为47% vs 86%,p=0.009。
- ypT1R1/T2-3未行CTME者10年局部复发率为79%。
临床怎么用
- 对于局部切除候选的早期直肠癌,放化疗可能较短程放疗带来更好的局部控制和生存。
- ypT1R1/ypT2-3患者应强烈考虑补行全直肠系膜切除术以降低局部复发风险。
局限性
- 样本量小(51例分析),存在偏倚风险。
- 需确证性研究验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: It is uncertain whether local control is acceptable after preoperative radiotherapy and local excision (LE). An optimal preoperative dose/fractionation schedule has not yet been established. MATERIAL AND METHODS: In a phase III study, patients with cT1-2N0M0 or borderline cT2/T3N0M0 < 4 cm rectal adenocarcinomas were randomised to receive either 5 × 5 Gy plus 1 × 4 Gy boost or chemoradiation: 50.4 Gy in 28 fractions plus 3 × 1.8 Gy boost and 5-fluorouracil with leucovorin bolus. LE was performed 6-8 weeks later. Patients with ypT0-1R0 disease were observed. Completion total mesorectal excision (CTME) was recommended for poor responders, i.e. ypT1R1/ypT2-3. RESULTS: Of 61 randomised patients, 10 were excluded leaving 51 for analysis; 29 in the short-course group and 22 in the chemoradiation group. YpT0-1R0 was observed in 66% of patients in the short-course group and in 86% in the chemoradiation group, p = 0.11. CTME was performed only in 46% of patients with ypT1R1/ypT2-3. The median follow-up was 8.7 years. Local recurrence incidences and overall survival at 10 years were respectively for the short-course group vs. the chemoradiation group 35% vs. 5%, p = 0.036 and 47% vs. 86%, p = 0.009. In total, local recurrence at 10 years was 79% for ypT1R1/T2-3 without CTME. CONCLUSIONS: This trial suggests that in the LE setting, both local recurrence and survival are worse after short-course radiotherapy than after chemoradiation. Because of the risk of bias, a confirmatory study is desirable. Lack of CTME is associated with an unacceptably high local recurrence rate.
引用
- Wawok P, Polkowski W, Richter P, et al. Preoperative radiotherapy and local excision of rectal cancer: Long-term results of a randomised study. Radiother Oncol. 2018. PMID: 29680321. doi:10.1016/j.radonc.2018.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。